Cite
APA Citation
Czarnecka, A. M., Kawecki, M., Lian, F., Korniluk, J., & Szczylik, C. (2015). feasibility, efficacy and safety of tyrosine kinase inhibitor treatment in hemodialyzed patients with renal cell cancer: 10 years of experience. Future oncology, 11, 2267–2282. http://access.bl.uk/ark:/81055/vdc_100147610736.0x000024